Company & Sponsor Intelligence
Peking Union Medical College Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting2
Completed1
Countries1
Therapeutic footprint
epilepsyneuromuscularout_of_scopestroke
Indexed studies
NCT03356769Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
epilepsy · ChinaPHASE2
epilepsy · ChinaPHASE2
NCT07475754A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy
neuromuscular · NA
neuromuscular · NA
NCT03167346The Investigation of Public Awareness of Core Stroke Symptoms
stroke · ChinaCOMPLETED
stroke · ChinaCOMPLETED
NCT07386795The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation
out_of_scope · ChinaNA
out_of_scope · ChinaNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →